Skip to main content
. 2023 Mar 3;28(5):2356. doi: 10.3390/molecules28052356

Figure 1.

Figure 1

Chemical structure of Ritonavir (left) and Nirmatrelvir (right), both composing Paxlovid®, clinically employed for the treatment of COVID-19.